Gilead's ARTISTRY-1 Phase III Trial Shows Promise with New HIV Treatment Gilead's ARTISTRY-1 trial reveals effective new single-tablet regimen for HIV-1 treatment, potentially expanding options for patients on complex regimens.

Gilead's ARTISTRY-1 Phase III Trial Shows Promise with New HIV Treatment #USA #Foster_City #Gilead_Sciences #Biktegravir #Rilpivirine